CA
NZ
UK
AU
IND
US
Cohen & Company Inc. (NYSE: COHN) has announced a groundbreaking innovation in the use of biological engineering in highway right-of-way technology, aiming to revolutionize road safety and sustainability. This pioneering move is poised to redefine the infrastructure development landscape.
Shares in Bio-Rad Laboratories Inc. (NYSE: BIO) dipped 0.77% to USD 303.77 during trading today, despite the company's operational transformation and targeted innovation efforts driving growth amid global market headwinds. This follows a busy day of trading for the biotechnology sector.
Registered nurses at Baystate Franklin Medical Center, represented by the Massachusetts Nurses Association (MNA), will hold a banner action outside the Baystate Health &Amp; Wellness Center in Northampton on June 8, 2026, as they continue their fight for a fair union contract. This action …
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) has been upgraded to 'Outperform' from 'Sector Perform' by RBC Capital analysts. This notable change reflects the firm's renewed confidence in the company's prospects. This significant move demonstrates their revised stance on the firm's growth andRevenuetrajectory.
Arvinas, Inc. (NASDAQ: ARVN) secured the first PROTAC approval, marking a significant milestone for the company. This regulatory breakthrough underscores ARVN's commitment to pioneering degrader technology, a key area of focus in the pharmaceuticals sector.
This article is intended for informational purposes only and does not constituteInvestmentadvice or a recommendation to buy, sell, or hold any security. All information is sourced from publicly available data. Investors should conduct their ownDue Diligenceand consult a qualified financial adviser before making any …
Piper Sandler has initiated coverage of Agilysys Inc. (NASDAQ: AGYS) with an Overweight rating. This development is significant for the technology company, which has been navigating various market challenges in recent times. The rating highlights theInvestment Bankingfirm's confidence in the company's growth prospects.
The drones-as-a-service market has experienced a significant surge in growth, driven by AI, automation, and industrial demand. According to a recent report, the global DaaS market is expected to reach $8.2 billion by 2026, up from approximately $6.3 billion in 2024. This growth is …
The company's AI-powered innovation and proprietary data have been driving growth, efficiency, andMarket Sharegains. AI-enabled products deliver significant performance lifts, while cloud transformation and disciplined M&A supportLong-term Growth.Marginexpansion and productivity gains are ahead of plan.
Market reaction to the news has been muted, with Dyne Therapeutics, Inc.'s (NASDAQ: DYN) stock price dipping 0.06% to USD 17.23, as the broader market trends overshadowed this specific announcement. The day's trading range has been USD 17.21 – 17.64, which suggests a relatively …
Please wait processing your request...